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INTRODUCTION  
Parkinson’s disease (PD) is a neurodegenerative movement disorder induced by a progressive
loss of dopamine cells in the pars compacta of the substantia nigra (SNpc), leading to dopamine
depletion in the striatum6). Since the discovery of the dopamine precursor, levodopa, it has
remained as the most effective medical treatment for PD. However, after several years of
exposure to levodopa, the majority of patients develop on-off motor fluctuations, painful
dystonia, wearing-off phenomena and levodopa-induced dyskinesia19). The mechanisms
underlying the motor complications in PD remain poorly understood. However, it is now
well known that deep brain stimulation (DBS) of the subthalamic nucleus (STN) is reported
to decrease motor fluctuations and dyskinesia in patients with PD despite the fact that most
patients continue to take levodopa14). The STN lesion in the rat also normalizes the decreased
activity of globus pallidus internus (Gpi) in the rat with a previous medial forebrain bundle
(MFB) lesion20). Thus, both strategies, dopamine agonist administration and STN lesion
in the rat, might have a synergistic effect on the neuronal activities of substantia nigra pars
reticulata (SNpr) as observed in PD patients treated with bilateral DBS.
In this study, the effects of SKF38393 (a D1 agonist) and Quinpirole (a D2 agonist) were
compared in parkinsonian rat models with 6-hydroxydopamine (6-OHDA) after STN lesion.
To investigate these effects, the changes of the firing rates and firing patterns of SNpr neurons
were analyzed. 
Objective : It was hypothesized that dopamine agonist administration and subthalamic nucleus (STN) lesion in
the rat might have a synergistic effect on the neuronal activities of substantia nigra pars reticulata (SNpr) as
observed in patients with Parkinson’s disease. The effects of SKF38393 (a D1 receptor agonist) and Quinpirole
(a D2 receptor agonist) were compared in parkinsonian rat models with 6- hydroxydopamine (6-OHDA) after
STN lesion.   
Methods : SKF38393 and Quinpirole were consecutively injected intrastriatally. SNpr was microrecorded to
ascertain the activity of the basal ganglia output structure. The effect of SKF38393 or Quinpirole injection on
the firing rate and firing patterns of SNpr was investigated in medial forebrain bundle (MFB) lesioned rats and
in MFB+STN lesioned rats. 
Results : The administration of SKF38393 decreased SNpr neuronal firing rates and the percentage of burst
neurons in the MFB lesioned rats, but did not alter them in MFB+STN lesioned rats. The administration of
Quinpirole significantly decreased the spontaneous firing rate in the MFB lesioned rats. However, after an
additional STN lesion, it increased the percentage of burst neurons. 
Conclusion : This study demonstrated that dopamine agonists and STN lesion decreased the hyperactive firing
rate and the percentage of burst neurons of SNpr neurons in 6-OHDA lesioned rats, respectively. Quinpirole with
STN lesion increased a percentage of burst neurons. To clear the exact interactive mechanism of D1 and D2 agonist
and the corresponding location, it should be followed a study using a nonselective dopamine agonist and D1, D2
selective antagonist. 
KEY WORDS : 6-hydroxydopamine·Substantia nigra pars reticulate·Kainic acid·Subthalamic nucleus·
Dopamine agonist·Parkinson’s disease.
MATERIALS AND METHODS  
Surgical procedures for MFB and STN lesions
Male adult Sprague-Dawley rats weighing 200-250 g were
used for the first surgical procedure. Rats were divided into 4
groups:(i) control group, 7 rats without lesions; (ii) 6-OHDA
lesioned group, 7 rats that had an MFB lesion induced by
6-OHDA; (iii) 6-OHDA+STN lesioned group, 7 rats with
a 6-OHDA lesion of MFB plus a STN lesion, induced by
kainic acid; and (iv) 6-OHDA+STN sham group, 7 rats
treated with saline instead of kainic acid in STN. Five animals
per group were housed in a temperature-controlled room
on a 12 hr-light/12 hr-dark schedule with free access to food
and water. Rats were anesthetized with a mixture of ketamine
(75 mg/kg), acepromazine (0.75 mg/kg) and rompun (4
mg/kg) and mounted in a stereotaxic apparatus. Six-OHDA
hydrobromide (Sigma, St Louis, MO, 8 μg free base in 0.2%
ascorbic acid) was injected into unilateral MFB according
to the following stereotaxic coordinates : AP-4.4 mm, ML
1.2 mm relative to bregma, and DV -7.5 mm from the dura.
The injection was made at a rate of 0.5 μl/min using a
cannula, and was controlled using a Hamilton microsyringe.
A polyethylene tube connected the cannula and the micro-
syringe. To prevent the noradrenergic neurons being destroyed,
desipramine (12.5 mg/kg, i.p.) was administered 30 min
prior to the 6-OHDA infusion. The unilateral STN lesion
was achieved by injecting 1μg of kainic acid (Sigma, St
Louis, MO) dissolved in 0.5 μl of saline into the right STN
(coordinates : AP -3.8 mm, ML 2.5 mm relative to bregma,
and DV-8.0 mm from the dura) at the rate of 0.25 μl/min.
In the group of rats with combined lesions (6-OHDA+STN
lesion), the STN lesion was performed 3 weeks after the
6-OHDA lesion. Sham lesion was performed by using the
same protocols as used for the combined lesions, but saline
was injected instead of kainic acid. The apomorphine-induced
contralateral turning response (0.1 mg/kg i.p.) was performed
at 2 weeks after MFB lesioning to select the rats bearing
successful lesion.
Extracellular microrecordings
The electrophysiological recording was performed 5 weeks
after the 6-OHDA lesion in all rats. STN lesions were per-
formed 2 weeks before the recording (Fig. 1). Extracellular,
single unit recordings were undertaken in rats anesthetized
with urethane (1.3 mg/kg i.p.). A glass microelectrode
(impedance, 7-10 Mohm) filled with 2.5% Pontamine sky
blue in 0.5 M sodium acetate buffer (pH 7.6) was used to
investigate the single recordings. Microelectrodes were
stereotaxically guided through a drilled skull burr hole to the
target coordinates (SNpr : AP-5.3 mm, ML 2.4 mm relative
to bregma, and DV 7.5-8.0 mm from the dura). Electrical
signals were amplified using a DAM80 preamplifier (WPI,
UK) in bridge mode, displayed on a storage oscilloscope
and monitored with an audio amplifier. Single unit activity
was isolated with a window discriminator, and firing rate
data were collected on a computer equipped with Spike 2
software (version 2.18, Cambridge Electronic Design, UK).
Visual inspection of digital neuronal activity and raster
displays were useful complements to the computer-based
analysis of the discharge patterns of these units. The isolated
units were monitored for at least 10 min to ensure the stability
of their firing rate, firing pattern and spike morphology, and
then 5-10 min of spontaneous activity was recorded. The
selective D1-class dopamine agonist SKF38393 (Sigma, St
Louis, MO, 10 nmol/0.5 μl), or the selective D2-class agonist
Quinpirole (Sigma, St Louis, MO, 10 μmol/0.5 μl) was
injected in the striatum [coordinates AP -0.8 mm, ML 3.0
mm relative to bregma, and DV 1.3 mm from the dura].
This procedure required less than 2 min, and the needle was
left in place until the end of the recording, when the location
of the tip of the recording microelectrode was marked, at -15
uA for 20-30 min, by an iontophoretic deposit of Pontamine
Sky Blue. 
The mean firing rate, the mean interspike interval (ISI),
autocorrelogram and discharge pattern were investigated
for each neuron. The ISIs allowed an evaluation of the
neurons’ degree of burst frequency, following an algorithm
described by Hutchison et al.10,11). Bursting cells had a degree
of burstiness score of more than 10, which was calculated
from the reciprocal of the modal interval divided by the
mean firing rate.
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Fig. 1. Flow chart of the processing. 6-OHDA : 6-hydroxydopamine;
STN : subthalamic nucleus.
Unilateral 6-OHDA lesion
STN lesion
Electrophysiological recording
Sacrifice
On day 14, Apomorphine rotation test
On day 28, Apomorphine rotation test
3 weeks
2 weeks
Histology and
immunohistochemistry
After the extracellular single unit
recording, rats were anesthetized and
transcardially perfused with 125 ml of
normal saline followed by 250 ml of
ice-cold 4% paraformaldehyde. Brains
were removed, postfixed for 10 hours,
and submerged in 30% sucrose until
equilibrated. Twenty micrometer sections
were cut and then immunoreacted with
a primary, polyclonal antibody against
rat tyrosine hydroxylase (TH, Pel-freeze,
Rogers, AK) at a dilution of 1 : 750, and
then with a biotinylated goat anti-rabbit
IgG (Vector Labs, Burlingame, CA)
secondary antibody. The signal was
amplified using avidin and biotinylated
horseradish peroxidase using an Elite
ABC Vectastain Kit (Vector, Burlingame,
CA). 3, 3’-Diaminobenzidine tetrachlo-
ride dehydrate was used as a chromogen
and cobalt chloride/nickel ammonium
was used to intensify color changes. This
immunostaining allowed the determi-
nation of the extent of dopaminergic
cell degeneration. Only rats with a total
loss of TH immunoreactivity were used
for the electrophysiological analysis.
The STN lesions and the localization
of the recorded basal ganglia nuclei
were studied in 20-μm sections stained with cresyl violet.
Data analysis
Statistical analysis was performed with the SPSS version
11.0 statistical software packages (SPSS Inc., Chicago, IL).
Comparisons of the firing rates from different rats in each
group were performed using analysis of variance (ANOVA).
Results showing significant differences between groups were
compared using Kruskal-Wallis one-way ANOVA and then
the Mann-Whitney U-test. Statistical significance was set
at p＜0.05.
RESULTS 
Histological findings of rat parkinsonian models
The extent and location of the lesions induced by 6-OHDA
were confirmed by assessing the loss of TH-immunoreactive
cells in SNpc in a rat parkinsonian model with 6-OHDA. All
6-OHDA lesioned rats used throughout these experiments
showed more than 100 full contralateral net turns during
1 hour after administration of apomorphine (0.1 mg/kg
i.p.). TH immunhistochemistry was used to confirm the
completeness of the 6-OHDA lesion of the nigrostriatal
pathway. All rats receiving unilateral 6-OHDA injections
showed almost total loss of TH-immunoreactive cells from
the substantia nigra and the striatum on the lesion side (Fig.
2). The STN lesions were also evaluated after conducting
the experiments and they revealed local gliosis at the STN
level. The cresyl violet Nissl staining was used to confirm the
completeness of the kainic acid lesion of the STN. All rats
receiving STN lesions showed virtually complete (＞90%)
cell loss in the STN, with little or no damage to surrounding
structures (Fig. 2). The localizations of the recorded SNpr
were also confirmed by cresyl violet staining (Fig. 2).
Effects of STN lesions on firing rate and firing patterns
In each group, the mean firing rates and the total number
of cells recorded are shown in Table 1. The number of cells
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Fig. 2. Photomicographs of a representative 6-OHDA lesion of the nigrostriatal bundle using
immunohistochemistry of tyrosine hydroxylase in the striatum (A) and kainic acid lesion of the STN
(B). The tyrosine hydroxlyase immunopositive cell shows total degeneration of dopamine cell body
in the lesion sides of the pars compacta of substantia nigra (C) compared to normal side (E). STN
lesion with kainic acid showing a nearly complete loss of neurons and an intense gliosis reaction
compared to the intact contra lateral side (D, F). Str : Striatum; SNpc : Substantia nigra pars
compacta; STN : Subthalamic nucleus; 6-OHDA : 6-hydroxydopamine.
A B
C D
E F
recorded per track was similar for each group. The firing
patterns in SNpr were classified into a regular non-burst
pattern and a burst pattern. In normal unlesioned rats, the
mean firing rates of neurons in SNpr (n=35) were 20±1.9
spikes/s (Table 1). Compared with the normal control rats,
parkinsonian rat models with 6-OHDA exhibited signifi-
cantly increased mean firing rates in SNpr (28±1.5 spikes/s,
p＜0.05). Following STN lesion in parkinsonian rats, the
mean firing rate in SNpr was reduced compared to that of
parkinsonian rats (21±1.8 vs. 28±1.5 spikes/s, respectively,
p＜0.05). No statistically significant
difference was observed between
the mean firing rates of MFB le-
sioned and sham STN lesioned
parkinsonian rats. Regular neurons
represented 76% of the neurons
in normal rats, and burst neurons,
24% (Fig. 3). In 6-OHDA lesioned
rats, the number of burst neurons
increased from 24% to 35%. The
STN lesions in the 6-OHDA lesion-
ed rats increased the percentage
of regular neurons to 87% in the
group of STN lesioned rats versus 76% in the normal rats.
Representative discharge pattern of units recorded from
SNpr of control group, MFB group, MFB+STN group, and
MFB+STN sham group were presented (Fig. 4).
Effects of SKF38393 on the firing rates and firing
patterns  
The effect of the D1 agonist, SKF38393, applied by intra-
striatal injection, on the firing rate of SNpr units is shown
in Table 1. The administration of SKF38393 decreased SNpr
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Fig. 3. The effects of D1 agonist (SKF38393) and D2 agonist (Quinpirole)
on the firing pattern of substantia nigra pars reticulata neurons in rat
parkinsonian models. A : The proportion of burst neurons in the substantia
nigra pars reticulata of each group. B : The effects of SKF38393 and
Quinpirole on the firing pattern of substantia nigra pars reticulata neurons
in rat parkinsonian models after the subthalamic nucleus lesion. MFB :
medial forebrain bundle; STN : subthalamic nucleus.
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Fig. 4. Representative discharge pattern of units recorded from substantia
nigra pars reticulata of contol group, MFB group, MFB+STN group, and
MFB+STN sham group. MFB : medial forebrain bundle; STN : subthalamic
nucleus.
A. Control 20±1.9 Hz
28±1.5 Hz
21±1.8 Hz
28±2.0 Hz
1 sec
B. MFB
C. MFB+STN
D. MFB+STN Sham
Table 1. Spontaneous activity of SNpr single units recorded from 6-OHDA lesioned rats with a kainic
acid lesion of the STN and intrastriatal selective D1, D2 agonist microinjection 
Control MFB MFB+STN MFB+STN sham
Control Neurons (n) 35 47 27 21
Mean firing rate (Hz) 20±1.9 28±1.5* 21±1.8 28±2.0
Interspike interval (sec) 0.047±0.0071 0.029±0.0036 0.037±0.0049 0.032±0.0056
SKF38393 Neurons (n) 16 25 18 14
Mean firing rate (Hz) 21±1.6 21±2.7 20±2.3 20±4.2
Interspike interval (sec) 0.033±0.0050 0.045±0.0074 0.041±0.0052 0.059±0.0150
Quinpirole Neurons (n) 12 24 15 11
Mean firing rate (Hz) 28±2.4* 16±1.3* 20±3.6 18±1.1
Interspike interval (sec) 0.026±0.0045 0.041±0.0079 0.036±0.0062 0.024±0.0083
The values mean±SEM. *p<0.05  in comparison with values from control subjects. SNpr : substantia nigra pars 
reticulata; 6-OHDA : 6- hydroxydopamine; MFB : medial forebrain bundle; STN : subthalamic nucleus
neuronal firing rates in 6-OHDA lesioned rats (from 28
±1.5 to 21±2.7 spikes/s, n=25), but did not significantly
alter the mean firing rate of SNpr neurons in the intact rat (21
±1.6 vs. the control at 20±1.9 spikes/s, n=16). SKF38393
did not alter the mean neuronal firing rate in the SNpr
neurons of MFB+STN lesioned rats (20±2.3 vs. 21±1.8
spikes/s, respectively, n=18). In rats with 6-OHDA lesions
of MFB, SKF38393 induced a decrease in the percentage
of burst neurons (from 35% to 21%). Additional SKF38393
injection in STN lesioned and MFB lesioned rats increased
the percentage of burst neurons (from 13% to 15%) but the
change was not significant. 
Effects of Quinpirole on the firing rate and firing
patterns
The excitatory effect of dopamine on the neuronal activity
of STN in parkinson’s disease appeared to be largely via the
dopamine D2-like receptor agonist. Quinpirole increased
the mean firing rate of SNpr neurons in normal rats from
20±1.9 to 28±2.4 spikes/s (p＜0.01). However, in neurons
prepared from 6-OHDA lesioned rats, Quinpirole decreased
the spontaneous firing rate from 28±1.5 to 16±1.3 spikes/s
(p＜0.01). In rats with 6-OHDA lesions of MFB, Quinpirole
induced a significant change in the percentage of burst
neurons (from 35% to 25%). However, Quinpirole after
the additional STN lesion in rats with 6-OHDA lesions of
MFB induced a significant increase in the percentage of
burst neurons (from 13% to 27%).
DISCUSSION  
Effects of STN lesions on the firing rates and firing
patterns of SNpr in rat parkinsonian model
In accordance with predictions, our data demonstrated
that SNpr neurons recorded in rat parkinsonian models
also exhibited basal firing rates of SNpr neurons that were
faster in MFB lesioned rats (28±1.5Hz) than those observed
in SNpr of normal rats (20±1.9Hz). We observed that rat
PD models had more burst neurons (35%) in SNpr than
the control rats (24%). Following STN lesioning for the rat
PD models, the percentage of burst neurons decreased by
13% (p＜0.05). This finding suggested that STN lesion
decreased the percentage of SNpr burst neurons12).
However, several authors have reported controversial results.
Kreiss et al.13) reported that rat PD models had more regular
neurons in STN than the control rats did. Rohlfs et al.22)
reported that SNpr neuronal activity in rat parkinsonian
models was significantly lower than the respective activity in
the control groups, and that, in contrast, contralateral SNpr
neuronal activity in rat parkinsonian models was significantly
higher than the respective activity in the contralateral SNpr
neuronal activity of control rats. In addition to the significant
reduction in the mean firing rate, they also reported that
many neurons in SNpr on the lesioned side exhibited a burst
pattern. MacLeod et al.15) suggested that the continuous
burst type of firing could be an indication of a compensatory
physiological mechanism for the loss of spontaneous firing,
and that the decreased mean firing rate of ipsilateral SNpr
neurons, observed in rats within 2 weeks post-lesion, can be
explained by assuming a postsynaptic inhibitory action of
dopamine in the striatum. However, our data did not seem
to support these suggestions. All of our rat parkinsonian
models with 6-OHDA clearly demonstrated an increase in
the mean firing rates in SNpr. In addition, the results of
our rat PD models with STN lesions further supports the
theory that the mean firing rates in SNpr are reduced by
the presence of STN lesions. 
Effects of SKF38393 and Quinpirole on the firing
rates and firing patterns of SNpr in rat parkinsonian
model with STN lesion
The STN hyperactivity is based on the hypothesis that
the loss of dopamine in the striatum reduces the activity of
the inhibitory GABAergic pallido-subthalamic pathway1,16).
Our results also demonstrate that SKF38393 and Quinpirole
decreased the mean firing rate in SNpr of rats with MFB
lesion with 6-OHDA. However, we did not find a further
decrease in the SNpr firing rate after the administration of
SKF38393 or Quinpirole in additional STN lesions of MFB
lesioned rats with 6-OHDA. This may suggest that D2 agonist
has a stronger influence on the firing rates of SNpr because
it could affect the function of STN and pedunculopontine
nucleus12). The interaction between indirect pathway and
direct pathway, or some roles for STN in the genesis or
maintenance of SNpr neural activity might be considered
as well. 
Under the balanced condition between direct and indirect
pathways, which is a normal control group and an STN and
MFB lesioned group, augmentation of D1 receptor hardly
affected the firing rate and firing pattern of SNpr. However,
augmentation of D2 receptor resulted in increasing firing
rate (control group) and increasing the proportion of burst
neurons (MFB+STN group). This means D1 or D2 dopa-
mine agonist alone is not sufficient to affect the SNpr neural
activity. Other reports support the consistent results13,17). Kreiss
et al. indicated that the integration of dopamine D1 and D2
receptors rather than predominant action of dopamine D2
receptors was considered to regulate STN neuronal activity13).
Calabresi et al. reported that stimulation of both D1 and
D2 dopamine receptors is required for the expression of
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long term depression at the single cell level in striatal slices5).
Other in vitro studies have shown that D1 and D2 dopamine
receptors expressed in the same cell were able to interact
synergistically3,21). Gerfen et al. have demonstrated that D1
agonists are able to modify the expression of an immediate
early gene mRNA exclusively in striatal enkephalin-negative
neurons and that D2 agonists have an opposite effect exclu-
sively on enkephalin-positive neurons7). The coadministration
of D1 and D2 agonists produced a potentiated effect in
enkephalin-negative neurons. These results also suggest that
this synergistic action seen at the single cell level results from
interneuronal interactions between separate populations of
striatal neurons sensitive either to D1 or D2 receptor agonists.
While Other reports have shown that microiontophoretically
administered D1 and D2 dopamine receptor agonists do
not interact synergistically at the single cell level within the
striatum9,23), suggesting that the D1-D2 receptor interaction
could also involve other mechanisms. An alternative mech-
anism could be an interplay between the direct striatonigral
and the indirect striato-pallido-subthalamo-nigral pathways
at the SNr level, resulting in a greater number of responding
units in the SNr when both pathways are activated by the
appropriate dopamine receptor agonists. Alternatively, burst
activity could originate in other structures projecting to STN,
such as the sensorimotor cortex or the intralaminar thalamic
nuclei22).
Recent studies have provided evidence that an irregular
or burst firing pattern might correlate better than firing
rate with signs of PD2,8). In our experiment, the proportion
of burst neurons in SNpr of 6-OHDA lesioned rats was
significantly reduced by STN lesions. These results suggest
that the interruption of the indirect pathway by a STN lesion
regularizes the SNpr neuron discharge pattern in 6-OHDA
lesioned rats. From recent evidence, it appears that STN
participates in the genesis of the burst pattern activity of
globus pallidus (GP) and SNpr neurons in rats with 6-OHDA
lesions, and that STN lesions can reverse this abnormal
spontaneous pattern4,17,18).
CONCLUSION
This study demonstrated that dopamine agonists and STN
lesion decreased the hyperactive firing rate of SNpr neurons
in 6-OHDA lesioned rats, respectively. Concerning the firing
pattern, the STN lesion reduced the percentage of burst
neurons in 6-OHDA lesioned rats. However, Quinpirole
with STN lesion demonstrated a higher percentage of burst
neurons than did STN lesion in 6-OHDA lesioned rats.
D1-D2 receptor interactions may be considered. To clear the
exact interactive mechanism of D1 and D2 agonist and the
corresponding location, it should be followed by a study
using a nonselective dopamine agonist and D1, D2 selective
antagonist. 
References 
1. Albin RL, Young AB, Penney JB : The functional anatomy of basal
ganglia disorders. Trends Neurosci 12 : 366-375, 1989
2. Bergman H, Wichmann T, Karmon B, DeLong MR : The primate
subthalamic nucleus. II. Neuronal activity in the MPTP model of
parkinsonism. J Neurophysiol 72 : 507-520, 1994
3. Bertorello AM, Hopfield JF, Aperia A, Greengard P : Inhibition by
dopamine of (Na(+)+K+)ATPase activity in neostriatal neurons through
D1 and D2 dopamine receptor synergism. Nature 347 : 386-388, 1990
4. Burbaud P, Gross C, Benazzouz A, Coussemacq M, Bioulac B :
Reduction of apomorphine-induced rotational behaviour by subthalamic
lesion in 6-OHDA lesioned rats is associated with a normalization of
firing rate and discharge pattern of pars reticulata neurons. Exp Brain
Res 105 : 48-58, 1995
5. Calabresi P, Maj R, Mercuri NB, Bernardi G : Coactivation of D1 and
D2 dopamine receptors is required for long-term synaptic depression
in the striatum. Neurosci Lett 142 : 95-99, 1992
6. DeLong MR : Primate models of movement disorders of basal ganglia
origin. Trends Neurosci 13 : 281-285, 1990
7. Gerfen CR, Keefe KA, Gauda EB : D1 and D2 dopamine receptor
function in the striatum : coactivation of D1- and D2-dopamine receptors
on separate populations of neurons results in potentiated immediate
early gene response in D1-containing neurons. J Neurosci 15 : 8167-
8176, 1995
8. Hollerman JR, Grace AA : Subthalamic nucleus cell firing in the 6-
OHDA-treated rat : basal activity and response to haloperidol. Brain
Res 590 : 291-299, 1992
9. Hu XT, Wang RY : Comparison of effects of D-1 and D-2 dopamine
receptor agonists on neurons in the rat caudate putamen : an electro-
physiological study. J Neurosci 8 : 4340-4348, 1988
10. Hutchison WD, Allan RJ, Opitz H, Levy R, Dostrovsky JO, Lang
AE, et al : Neurophysiological identification of the subthalamic nucleus
in surgery for Parkinson’s disease. Ann Neurol 44 : 622-628, 1998
11. Hutchison WD, Levy R, Dostrovsky JO, Lozano AM, Lang AE :
Effects of apomorphine on globus pallidus neurons in parkinsonian
patients. Ann Neurol 42 : 767-775, 1997
12. Jeon MF, Ha Y, Cho YH, Lee BH, Park YG, Chang JW : Effect of
ipsilateral subthalamic nucleus lesioning in a rat parkinsonian model :
study of behavior correlated with neuronal activity in the peduncu-
lopontine nucleus. J Neurosurg 99 : 762-767, 2003
13. Kreiss DS, Mastropietro CW, Rawji SS, Walters JR : The response
of subthalamic nucleus neurons to dopamine receptor stimulation in a
rodent model of Parkinson’s disease. J Neurosci 17 : 6807-6819, 1997
14. Limousin P, Pollak P, Benazzouz A, Hoffmann D, Le Bas JF, Broussolle
E, et al : Effect of parkinsonian signs and symptoms of bilateral
subthalamic nucleus stimulation. Lancet 345 : 91-95, 1995
15. MacLeod NK, Ryman A, Arbuthnott GW : Electrophysiological
properties of nigrothalamic neurons after 6-hydroxydopamine lesions
in the rat. Neuroscience 38 : 447-456, 1990
16. Miller WC, DeLong MR : Altered tonic activity of neurons in the
globus pallidus and subthalamic nucleus in the primate MPTP model
of Parkinsonism. The basal ganglia. II., in. New York : Plenum, 1987,
Vol 32, pp415-427
17. Murer MG, Riquelme LA, Tseng KY, Cristal A, Santos J, Pazo JH :
D1-D2 dopamine receptor interaction : an in vivo single unit electro-
physiological study. Neuroreport 8 : 783-787, 1997
18. Ni ZG, Bouali-Benazzouz R, Gao DM, Benabid AL, Benazzouz A :
Time-course of changes in firing rates and firing patterns of subthalamic
nucleus neuronal activity after 6-OHDA-induced dopamine depletion
in rats. Brain Res 899 : 142-147, 2001
19. Obeso JA, Olanow CW, Nutt JG : Levodopa motor complications
in Parkinson’s disease. Trends Neurosci 23 : S2-7, 2000
20. Perier C, Marin C, Jimenez A, Bonastre M, Tolosa E, Hirsch EC :
Effect of subthalamic nucleus or entopeduncular nucleus lesion on
levodopa-induced neurochemical changes within the basal ganglia and
J Korean Neurosurg Soc 42｜December 2007
460
Effects of Selective Dopamine Receptor Agonists and Subthalamic Nucleus Lesioning on Parkinsonian Rats｜YS Park, et al.
461
on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned
rats. J Neurochem 86 : 1328-1337, 2003
21. Piomelli D, Pilon C, Giros B, Sokoloff P, Martres MP, Schwartz JC :
Dopamine activation of the arachidonic acid cascade as a basis for
D1/D2 receptor synergism. Nature 353 : 164-167, 1991
22. Rohlfs A, Nikkhah G, Rosenthal C, Rundfeldt C, Brandis A, Samii
M, et al : Hemispheric asymmetries in spontaneous firing characteristics
of substantia nigra pars reticulata neurons following a unilateral 6-
hydroxydopamine lesion of the rat nigrostriatal pathway. Brain Res
761 : 352-356, 1997
23. Shen RY, Asdourian D, Chiodo LA : Microiontophoretic studies of
the effects of D-1 and D-2 receptor agonists on type I caudate nucleus
neurons : lack of synergistic interaction. Synapse 11 : 319-329, 1992
